Literature DB >> 17616729

Intraluteal regulation of prostaglandin F2 alpha-induced prostaglandin biosynthesis in pseudopregnant rabbits.

M Zerani1, C Dall'Aglio, M Maranesi, A Gobbetti, G Brecchia, F Mercati, C Boiti.   

Abstract

The objective of the present study was to investigate in rabbit corpora lutea (CL), at both the cellular and molecular level, intraluteal cyclooxygenase (COX)-1, COX-2 and prostaglandin (PG) E2-9-ketoreductase (PGE2-9-K) enzymatic activities as well as in vitro PGE2 and PGF2alpha synthesis following PGF2alpha treatment at either early- (day-4) or mid-luteal (day-9) stage of pseudopregnancy. By immunohistochemistry, positive staining for COX-2 was localized in luteal and endothelial cells of stromal arteries at both the stages. In CL of both stages, basal COX-2 mRNA levels were poorly expressed, but rose (P < 0.01) 4- to 10-fold 1.5-6 h after treatment and then gradually decreased within 24 h. Compared to mid-stage, day-4 CL had lower (P < 0.01) COX-2 and PGE2-9-K basal activities, and PGF2alpha synthesis rate, but higher (P < 0.01) PGE2 production. Independent of luteal stage, PGF2alpha treatment did not affect COX-1 activity. In day-4 CL, PGF2alpha induced an increase (P < 0.01) in both COX-2 activity and PGF2alpha synthesis, whereas that of PGE2 remained unchanged. In day-9 CL, PGF2alpha up-regulated (P < 0.01) both COX-2 and PGE-9-K activities, and PGF2alpha production, but decreased (P < 0.01) PGE2 synthesis. All changes in gene expression and enzymatic activities occurred within 1.5 h after PGF2alpha challenge and were more marked in day-9 CL. Our data suggest that PGF2alpha directs intraluteal PG biosynthesis in mature CL, by affecting the CL biosynthetic machinery to increase the PGF2alpha synthesis in an auto-amplifying manner, with the activation of COX-2 and PGE-9-K; this may partly explain their differentially, age-dependent, luteolytic capacity to exogenous PGF2alpha in rabbits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616729     DOI: 10.1530/REP-06-0107

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  6 in total

1.  Patterns of gene expression in the bovine corpus luteum following repeated intrauterine infusions of low doses of prostaglandin F2alpha.

Authors:  Mehmet O Atli; Robb W Bender; Vatsal Mehta; Michele R Bastos; Wenxiang Luo; Chad M Vezina; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2012-04-27       Impact factor: 4.285

2.  Evidence for a dopamine intrinsic direct role in the regulation of the ovary reproductive function: in vitro study on rabbit corpora lutea.

Authors:  Francesco Parillo; Margherita Maranesi; Fiorenzo Mignini; Lisa Marinelli; Antonio Di Stefano; Cristiano Boiti; Massimo Zerani
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

3.  Kisspeptin/kisspeptin receptor system in pseudopregnant rabbit corpora lutea: presence and function.

Authors:  Margherita Maranesi; Linda Petrucci; Leonardo Leonardi; Antonello Bufalari; Francesco Parillo; Cristiano Boiti; Massimo Zerani
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

Review 4.  Current Knowledge on the Multifactorial Regulation of Corpora Lutea Lifespan: The Rabbit Model.

Authors:  Massimo Zerani; Angela Polisca; Cristiano Boiti; Margherita Maranesi
Journal:  Animals (Basel)       Date:  2021-01-25       Impact factor: 2.752

5.  The Effects of Prostaglandin E2 Treatment on the Secretory Function of Mare Corpus Luteum Depends on the Site of Application: An in vivo Study.

Authors:  Katarzyna K Piotrowska-Tomala; Agnieszka W Jonczyk; Anna Z Szóstek-Mioduchowska; Ewelina Żebrowska; Graca Ferreira-Dias; Dariusz J Skarzynski
Journal:  Front Vet Sci       Date:  2022-02-15

6.  Opposite effects of methanandamide on lipopolysaccharide-induced prostaglandin E2 and F2α synthesis in uterine explants from pregnant mice.

Authors:  Claudia A Vercelli; Julieta Aisemberg; Maximiliano Cella; Ana Inés Salazar; Manuel L Wolfson; Ana M Franchi
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.